Dear Colleague,

We would like to invite you to join us for the upcoming 23rd International Conference on Advancesin Critical Care Nephrology - AKI & CRRT 2018.

The CRRT Conference is a unique forum that continues to provide a comprehensive coverage of therapidly developing field of Critical Care Nephrology, AKI and CRRT. It highlights the recent advancesin our understanding of pathophysiology of critical illness, AKI, emerging strategies in the managementof sepsis, multi-organ failure, and the use of biomarkers to assess and manage patients with renal
dysfunction. This year's program presents exciting new developments and evidence for assessing critically ill patients with imaging techniques, new definitions of AKI in liver disease, cardiorenal syndrome
and key strategies to improve renal recovery. Experts will cover a wide-ranging review of the mostrecent technical advances in CRRT and the appropriate utilization of these techniques. Results of recently
completed trials for prevention of contrast induced AKI, management of shock, removal of endotoxin
in sepsis and the ISN AKI 0by25 initiative pilot study will be presented. A mix of invited lectures,controversies, interactive workshops, tutorials, poster sessions, panel discussions and meet the expert
sessions are planned to continue the tradition of multidisciplinary interactions throughout the conference.
Again this year we are offering two Pre-Conference workshops: the UAB/UCSD O’Brien AKI
Symposium titled Changing Paradigms in Acute Kidney Injury: From Mechanisms toManagement covering the most recent advances in basic and translational research and their applications to clinical care. The Practice Based Learning for CRRT workshop offers interactive case based
training to optimize the delivery of CRRT for nurses and physicians.

2018 Conference Topic Highlights:• Meet The Expert Sessions
Interact and Learn from Experts on How to Evaluate and Manage ICU Patients with
Difficult Clinical Problems• Organ Dysfunction in the Critically Ill Patient
Emerging Concepts in Organ Cross-talk, Sepsis, Liver and Cardiac Dysfunction, Infections• Results from ADQI Conferences on AKI Following Cardiac and Vascular Surgery
Updated consensus recommendations on pathophysiology, risk assessment andmanagement of patients with AKI post surgery• Controversies in Management of the Critically Ill Patient
Diuretic Use for AKI, Drug Induced Kidney Disease, RRT for End Stage Liver Disease,
Protecting the Kidney; Results from Trials in AKI and Sepsis• Challenges and Controversies in Renal Support & CRRT
When to Start and Stop, Co2 Removal, RRT for Sepsis, Drug Dosing and Hybrid Therapies• Biomarkers for Management of Critically Ill Patients
Risk Stratification, Surveillance, Diagnosis, Targeted Intervention and Prognosis• Special Sessions for Nurses and Allied Personnel
Skills Assessment, Workshops on CRRT, Plasma Exchange, Establishing Quality Metrics for
RRT in AKI, Post Intensive Care Syndrome and Difficult Conversations with Patients

As always, we are working to provide the right environment to foster learning and mutually beneficial
communications and collaborations. We hope that you will join us to share your knowledge and experience as it is through multidisciplinary interactions that we will gain a better understanding of critical
illness and it is only through our collective efforts that we will improve the lives of our patients. We
look forward to welcoming you to San Diego for the 23rd time.
Ravindra L Mehta, MBBS MD DM FACP FASN
Chairman, Organizing Committee

TWENTY THIRD INTERNATIONAL CONFERENCE ON
ADVANCES IN CRITICAL CARE NEPHROLOGYAKI & CRRT 2018
Endorsed by

The International Society of Nephrology
Acute Kidney Injury Network

ORGANIZING COMMITTEECHAIRMAn
Ravindra L. Mehta, MBBS, MD, DM, FACP, FRCP(UK)USA
Linda Awdishu, PharmD, MAS
David Askenazi, MD, MSPH
Rajit Basu, MD
Jorge Cerda, MD, FACP, FASN
Stuart Goldstein, MD
John Kellum, MD
Eileen Lischer, MA, BSN, RN, CNN
Bruce Mueller, PharmD, FCCP
Ashita Tolwani, MD
David M. Ward, MD, FRCP

IndIA
Rajasekara Chakravarthi, MD, DNB

SOUTH AMERICA
Emmanuel A. Burdmann, MD, PhD

TAIwAnVincent Wu, MD

EUROpE
Andrew Davenport, MD, FRCP
Patrick Honoré, MD, PhD
Claudio Ronco, MD
Miet Schetz, MD, PhD
JApAn
Kent Doi, MD, PhD, FASN
Hiroyuki Hirasawa, MD, PhD
CHInA
Xiaoquing Ding, MD
Li Yang, MD

CAnAdA
Noel Gibney, MD
Ron Wald, MD

AUSTRALIA
Zoltan Endre, MD, PHD

MALAYSIA
Bak Leong Goh, MD

IMPORTANT CONFERENCE DATESAbstract Submission (see page 5)

Online Registration Begins

Deadline for Receipt of Abstracts (see page 5)

December 12, 2017

Notification of Abstract AcceptanceJanuary 5, 2018

Deadline for Early Bird Registration

January 19, 2018

Hotel Reservation Deadline

On-site Registration Fees Begin

Pre-Conference Elective AKI Symposium - PW1 (see page 4)

Pre-Conference Elective CRRT Workshop - PW2 (see page 4)

Poster Mounting and Viewing

Plenary and Standard Workshop Sessions

Now Open

November 1, 2017

1

February 3, 2018

February 17, 2018
March 6, 2018

March 6, 2018

March 6, 2018

March 7-9, 2018

Inder Anand, Md
Minneapolis, MN USA
Anupam Agarwal, Md
Birmingham, AL USA
Sanjay Agarwal, Md
New Delhi, INDIA
Steven Alexander, MD
Stanford, CA USA

John Arthur, Md
Little Rock, AR USA
Tarek M. Ashkar (El-Achkar)
Indianapolis, IN USA
David Askenazi, MD, MSPH
Birmingham, AL USA
Linda Awdishu, PharmD, MAS
La Jolla, CA USA
Sean Bagshaw, MD
Alberta, CANADA
Erin Frazee Barreto, MD
Rochester, MN USA
Jonathan Barasch, MD
New York, NY USA
Rajit Basu, MD MMI
Cincinnati, OH USA
Azra Bihorac, MD MS
Gainesville, FL USA
Kate Bramham, MBBS, PhD
London, ENGLAND (UK)
Emmanuel Burdmann, MD, PhD
Sao Paulo, SP BRAZIL
Jorge Cerda, MD, FACP, FASN
Albany, NY USA
Rolando Claure-Del Granado, MD,
FASN
Cochabamba, Co BOLIVIA
Michael Connor, MD
Atlanta, GA USA
Laura Crotty-Alexander
San Diego, CA USA
Andrew Davenport, MD
London, ENGLAND (UK)
Xiaoquiang Ding, Prof
Shanghai, CHINA
Zoltan Endre, MD
Sydney, AUSTRALIA
Geoffrey Fleming, MD
Nashville, TN USA
Lui Forni, MD
Guildford, UK
Noel Gibney, MB FRCP(C)
Edmonton, AB CANADA
Sandra Kane Gill, MD
Pittsburgh, PA USA
Stuart Goldstein, MD
Cincinnati, OH USA

Volker Haase, MD
Nashville, TN USA

Hiroyuki Hirasawa, MD
Chiba, JAPAN

Patrick Honoré, MD, PhD
Jette, Br BELGIUM

FACULTY

Rajiv Jalan, MD
London, Gr UNITED KINGDOM
Michael Joannidis, MD
Innsbruck, AUSTRIALuis Juncos, MD
Jackson, MS USA
Nithin Karakala, MD
Little Rock, AK USA
Kianoush Kashani, MD
Rochester, MN USA
John Kellum, MD
Pittsburgh, PA USA
Jay Koyner, MD
Chicago IL USA

Vivek Kumar, MD
Chandigarh, INDIADavid Leaf, MD
Boston, MA USA
Andrew Lewington, MD
Leeds, YK UNITED KINGDOM
Andreas Linkermann, MD
Dresden, GERMANY
Eileen Lischer, MA, BSN, RN, CNN
San Diego, CA USA
Kathleen Liu, MD, PhD, MAS
San Francisco, CA USA
Etienne Macedo, MD, PhD
San Diego, CA USA
Magdalena Madero-Rovalo, MD
Mexico City, MEXICO
Alan Maisel, MD
San Diego, CA USA
Roslyn Mannon
Birmingham, AL USA
Isagani Marquez, BSN, RN
San Diego, CA USA

peter McCullough, Md, MpH
Dallas, TX USA
Ravindra Mehta, MBBS, MD, DM,
FACPSan Diego, CA USA
Theresa Mottes, BSN, RN, CDN
Cincinnati, OH USA
Patrick Murray, MD
Dublin, D IRELAND
Mitra Nadim, MD
Los Angeles, CA USA
Eisei Noiri, MD, PhD
Tokyo, JAPANNoel Oabel, BSN, RN, CNN
San Diego, CA USA
Mark Okusa, MD
Charlottesville, VA USA
Marlies Ostermann, MD
London, Gr UK
Paul Palevsky, MD
Pittsburgh, PA USA
Peter Pickkers, MD, PhD
Nijmegen, NETHERLANDS

2

Michael Pinsky, MD
Pittsburgh, PA USA
John Prowle, MA MSc MD FRCP
FFICM
London, UK
Qi Qian, MD
Rochester, MN USA
Hamid Rabb, MD
Baltimore, MD USA
Zaccaria Ricci, MD
Rome, ITALYClaudio Ronco, MD
Vicenza, ITALY
Mitchell Rosner, MD
Charlottesville, VA USA
Amber Sanchez, MD
San Diego, CA USA
Paul Sanders, MD
Birmingham, AL USA
Miet Schetz, MD, PhD
Leuven, BELGIUM
Nicholas Selby, MD
Derby, UK
Andrew Shaw, MD
Nashville, TN USA
Teri Shell, RN
Birmingham, AL USA

Edward Siew, MD
Nashville, TN USA

Prabhleen Singh, MD
San Diego, CA USA

Robert Star, MD
Rockville, MD USA
Swami Sundararaman, MD
Charlottsville, VA USA
Scott Sutherland, MD
Stanford, CA USA
Jordan Symons, MD
Seattle, WA USA
Ashita Tolwani, MD
Birmingham, AL USA
James Tumlin, MD
Atlanta, GA USA
Volker Vallon, MD
San Diego, CA USA
John Louis Vincent, MD, PhD
Brussels, NA BELGIUMDavid Ward, MD
San Diego, CA USA
Keith Willie, MD
Birmingham, AL USA
Francis Perry Wilson, MD
New Haven, CT USA
Vincent Wu, MD
Taipei, TAIWAN
Li Yang, MD
Beijing, CHINA
Alex Zarbock, MD
Munster, NR GERMANY

GEnERAL InFORMATIOn

Visit our website for the most current program information, abstract submission,
online registration (reg. form download available) and online hotel reservations.

www.crrtonline.com

COnFEREnCE dATES And LOCATIOn

The inclusive dates for all scientific sessions of the TwEnTY THIRd InTERnATIOnAL
AKI & CRRT COnFEREnCE are March 6-9, 2018. The Conference will be held at the
Manchester Grand Hyatt, 1 Market Place, San Diego, CA 92101, Tel: (619) 232-1234. Online
Reservations are available directly with the hotel by using Hotel Reservations link on the conference
website. Group reservations of 5 or more hotel rooms need to contact the conference administration
directly at 858-272-1018.

REGISTRATIOn InFORMATIOnplease visit our website to register (online registration required, printable form available).
All participants must register and pay the appropriate fee. Fee includes access to all Plenary
Sessions, Standard Workshops, Exhibit Area, Welcome Reception & Poster Sessions (Tue.),
Exhibit Reception (Wed.), CME Accreditation, Conference Syllabus (digital media), two Lunches(Wed. & Thur.), two Breakfasts (Wed. & Thur.) and all conference coffee breaks. Conference
Registration Fee DOES NOT include Elective Events on Tuesday. (see page 4 & 5 for list).
Registration check-in will begin on Monday, March 5, 2018. Poster Viewing will begin on Tuesday
evening March 6, 2018. For additional registration times see the program.

REGISTRATIOn FEES

Physicians/Other (MD, PhD, etc.)
With Multimedia Package

Nurses/Dieticians/
Pharmacists/Residents*/Fellows*
With Multimedia Package
Industry
With Multimedia Package*with letter of verification from department head

Early Bird
On or before
Jan. 19, 2018

Pre-Registration
Jan. 20, 2018 thru
Feb. 16, 2018

On-Site Registration

$ 530
$ 730

$ 630
$ 830

$ 675
$ 875

$ 730
$ 930
$ 730
$ 930

$ 830
$ 1,030$ 830$ 1,030

Feb. 17 thru
Mar. 10, 2018

$ 895
$ 1,095$ 895$ 1,095

pRE-COnFEREnCE ELECTIVE SYMpOSIUM & wORKSHOp FEESPW1 AKI, PW2 CRRT
$ 240
$ 260
$ 280
PW1 with Multimedia Package
$ 365
$ 385
$ 405
PW1 AKI without full conference reg. $ 270
PW1 only with Multimedia Package$ 395

MEET THE EXpERT BREAKFAST SESSIOnS

$ 290
$ 415

$ 310
$ 435

(with registration) $50

These breakfast sessions (choose from 2 on Wed., Thurs. & Fri.) allow participants to meet andinteract with internationally renowned experts in an informal setting over breakfast. This is an
excellent opportunity to ask questions, learn how these experts manage patients, get guidancefor projects and network. See pages 10, 13 and 15 for titles and faculty.

OnLInE MULTIMEdIA pRESEnTATIOnS(with registration) $200

We will record all 7 PLENARY SESSIONS and select symposia for post-conference viewing
online. Add this package to your registration to review presentations in a state-of-the-art format
that includes streaming audio and video, and synchronized slides. Please visit the conference
website for details regarding the presentations & free demo lecture.
3

PRE-CONFERENCE ELECTIVE EVENTS (CME Available)
AKI SYMPOSIUM (see page 3 for fees)

Presented by UAB/UCSD O’Brien Center for AKI Research

TUESDAY, MARCH 6 - Full Day*(limited enrollment, full program on page 8)

CRRT Conference Attendance is NOT Required for this Symposium. See website for details!

PW1: Changing Paradigms in Acute Kidney Injury:
From Mechanisms to Management
7:55am-5:30pm (includes 12:15 lunch, AM & PM breaks)

Acute Kidney Injury is a rapidly evolving area where several advances have been made in understanding themechanisms and pathways of AKI and its effects on other organs. Recent identification of biomarkers has
provided new tools and techniques to characterize this disorder. This pre-course will provide a comprehensive
review of the most recent developments in the field and describe emerging knowledge from basic andtranslational research applicable to clinical care.
* A $30 discount will be given to attendees that register for the CRRT Conference. To receive the discount you
must sign up for this symposium at the same time you register for the conference.

CRRT WORKSHOP (see page 3 for fees)

TUESDAY, MARCH 6 - Full Day (limited enrollment, full program on page 9)

PW2: Practice Based Learning in CRRT: The Science and the Art
7:45am-5:30pm (includes lunch, AM & PM breaks - CRRT Conference Registration Required)This interactive workshop is designed to provide participants with the knowledge and understanding for decision
making for the effective utilization of CRRT to manage critically ill patients. The workshop will utilize case
based discussions to illustrate the underlying concepts for application of CRRT. All participants will be
provided access to digital media encompassing a core curriculum of articles and powerpoint lectures on CRRT
(accessible online).
The morning session will utilize patient cases to describe the key principles of CRRT and its application.
Afternoon sessions for physicians and nurses, in separate tracks, will describe the key features of CRRT.
Physicians will be guided on the machine user interface and the strategies for prescribing dose for solute andfluid management, adjustments in therapy parameters, recognition and management of complications. Nurses
and technicians will learn how to set up CRRT for different modalities, maintain circuit patency, deliver theprescribed dose for solute and fluid management and recognize different alarm conditions and troubleshooting
and charting and monitoring of the therapy. At the end of this workshop participants will have an improved
understanding of how to utilize CRRT for optimizing renal support. A quiz will be administered pre-and postcourse for assessment.

SOCIAL ACTIVITIES (Non-CME)

Welcome Reception and Poster Review

Tuesday, March 6, 2018

5:30-7:00pm

Exhibit Reception and Poster Session

Wednesday, March 7, 2018

6:00-8:00pm

All attendees are invited to review the CRRT poster presentations including fellows in training and meetthe presenters and faculty. This is a great opportunity to pick-up credentials, register on-site, organize yourworkshops and prepare for the upcoming CRRT meeting. Light appetizers & refreshments will be served.
Meet and interact with CRRT poster presenters while you review the latest in equipment and products. Thisis a great opportunity to network and meet your colleagues. Light appetizers & refreshments will be served.

ADDITIONAL OPTIONAL SESSIONS (Non-CME)

INDUSTRY BREAKFAST AND LUNCH SYMPOSIA - see website for details
Wednesday, March 7 - Luncheon
12:30-2:00pm (Non-CME)
The Importance of a Quality Assurance Program for a CRRT
Thursday, March 8 - Luncheon 12:30-2:00pm (Non-CME)
Cytokine Removal in Critical Care and Cardiac Surgery - Update on Evidence andClinical Experiences
Friday, March 9 - Breakfast
6:45-8:00am
Optimizing Care in the ICU Through Use of Novel Dialysis Technology (Non-CME)
Seating LIMITED for these sessions - Selection made during registration

4

ABSTRACT InFORMATIOndEAdLInE FOR RECEIpT OF ABSTRACTS: december 12, 2017
Abstract Submission Via Our website is Required: www.crrtonline.com

GEnERAL InFORMATIOn
1.
2.
3.
4.

5.

6.
7.

The abstract must be written in English.
Deadline: abstracts MUST BE RECEIVEd no later than december 12, 2017.
Online abstract submissions are required. See website for details: www.crrtonline.com
Presenting authors must pay the registration fee and attend the meeting. Authors of accepted
abstracts are not provided with travel funds.
All accepted abstracts will be published and distributed electronically in the CRRT Conference
Syllabus. Hardcopy syllabus booklets will be available for purchase during the conference.
Abstracts and digital posters (if submitted) will also be published online at: www.crrtonline.com
Notification of acceptance will be mailed by January 5, 2018.
Selected abstracts will be eligible for digital poster discussions with experts on Tuesday,
March 6 and 7 from 5:30-7:00pm. details will be provided with notification of acceptance.

COnTEnT OF THE ABSTRACT
1.
2.
3.
4.
5.
6.
7.
8.

9.

Abstracts are limited to 2500 characters. Please see sample on website: www.crrtonline.com/conference/
Abstract Body: purpose of the study, methods used, summary of the results and conclusion reached.
Author list is limited to 10.
References and credits MUST nOT be included in the abstract.
Simple tables, figures and graphs may be included, but avoid the use of special characters.
Formulas should be avoided.
Use standard abbreviations in parentheses after the full word appears the first time.
Please indicate the subject category your abstract most closely represents:a) Epidemiology and Outcomes from AKI, b) Research in AKI (Basic, translational, clinicalincluding clinical trials), c) RRT Technique Characteristics, d) RRT Applications and TargetedInterventions, e) New Technology, f) RRT Research, g) Nursing Issues (education, training, care delivery)
Abstracts will be published as submitted. Proof and edit your submission accordingly.

TRAVEL And REGISTRATIOn AwARdS

Fellows in an accredited training program, nurses and allied professionals who submit a poster abstract
to be presented at the CRRT Conference by December 12 are eligible to apply for Registration andTravel Awards for the conference. Awards will be based on the quality and relevance of the research as
judged by the abstract review committee. Awards will be provided based on availability of funds.
The top three abstracts will be recognized. Award recipients are required to be present at their poster
session on Tuesday, March 6 and Wednesday, March 7, 2018.
1. Registration Awards - Conference reg fee. includes plenary sessions and standard workshops.
2. Travel Awards - Checks for up to a maximum of $500 will be presented at the time of the conference.
3. Recognition Awards - The top three abstracts will be awarded recognition awards.

CRITERIA FOR GRAnTS And/OR AwARdS
1.

2.
3.

4.
5.

Submit a poster abstract (via CRRT web site) and present a poster in the topics covered in the
CRRT conference at the Poster Sessions: Tuesday, March 6 and Wednesday, March 7, 2018.
Fellows must be currently enrolled in an accredited fellowship program in their host country.
Submit a signed letter (same time as abstract) from their program director verifying theircurrent status in the program. nOTE: Signed letter must be faxed or emailed to CRRT
administration office (fax: 1-858-272-7687 or res@crrtonline.com) on the same date as submissionof abstract. Abstracts submitted without dated faxed letter will not be accepted for Grants.
Designate request for financial support on the CRRT website abstract application form.
Fellows must attend an offered workshop.

SUBMISSIOn
1.

2.

Notification of acceptance will be mailed by January 5, 2018 with additional information
regarding poster dimensions, digital file submission and presentation of your poster.
For additional information or if you are unable to complete an online submission contact:
RES Seminars
4425 Cass Street, Suite A
San Diego, CA 92109 USA

Phone:
Fax:
Email:

5858-272-1018
858-272-7687
res@crrtonline.com

Website: crrtonline.com

CME InFORMATIOn

LEARnER OBJECTIVESThe CRRT conference provides a comprehensive review of advances in clinical care, research andtechnology in critical care medicine with a focus on the kidney and renal support techniques. The
conference is designed to facilitate interdisciplinary interactions among caregivers involved in the
management of patients in intensive care units. Physicians, nurses, pharmacists, nutritionists andother allied personnel from industry have opportunities to learn from each other. The conference
utilizes a combination of invited lectures; case based small group workshops, debates, hands oninteractive and simulation based workshops. Attendees have an opportunity to interact with thefaculty through focused panel discussions and symposia.

At the end of this conference attendees should be able to:
1. Describe the recent advances in the pathophysiology and management of critically illpatients with a focus on sepsis, multi-organ failure, infections, lung and kidney injury in
different settings.
2. Discuss the best ways to identify, treat and follow up patients with acute kidney injury (AKI)
resulting from different causes utilizing biomarkers, imaging and lab studies and applying
educational tools to raise awareness of AKI.
3. Describe the principles and practice of renal replacement techniques including CRRT, IHD
and plasma exchange and demonstrate how to setup and use these techniques for managing
critically ill patients.

ACCREdITATIOn STATEMEnTThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME)
through the joint providership of The University of California, San Diego School of Medicine
and CRRT, Inc. The University of California, San Diego School of Medicine is accredited by
the ACCME to provide continuing medical education for physicians.

The University of California, San Diego School of Medicine designates this live activity for a
maximum of 32.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.

BRN: For the purpose of recertification, the American Nurses Credentialing Center accepts
AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the
purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category
1 Credits™ (report up to 32.25 hours of credit and list "CME Category 1" as the provider number).

nEEdS ASSESSMEnT

Several sources of information were utilized to identify the practice gaps prompting thiseducational conference. These include literature review of multiple publications in Pubmed,
publications from the American Society of Nephrology, International Society of Nephrology,
ERA-EDTA, Critical care societies and published KDIGO and European Best Practice and
NICE guidelines and feedback from participants and faculty at prior CRRT conferences anddiscussions with the international organizing committee.

TARGET AUdIEnCE

The CRRT target audience includes: MD/DOs, NP/PA/Nurses, Dieticians, Industry,
Pharmacists, Residents and Fellows. Specialties include: Anesthesiology, Cellular &Molecular Medicine, Critical Care, Emergency Medicine, Family & Preventive Medicine,
Geriatrics, and Internal Medicine.
6CME CREdIT

CME InFORMATIOn

The following Workshops, Plenary Sessions and Electives qualify for CME Credit:

TUESdAY, MARCH 6, 2018
ELECTIVES: PW1 Changing Paradigms in AKI, PW2 Practice Based Learning in CRRT

wEdnESdAY, MARCH 7, 2018
MEET THE EXPERT SESSIONS, BREAKFAST SYMPOSIA, LUNCH SYMPOSIASESSION I: PATIENT CHARACTERISTICSGROUP 1 - WORKSHOPS, GROUP 2 - WORKSHOPS

THURSdAY, MARCH 8, 2018
MEET THE EXPERT SESSIONS, BREAKFAST SYMPOSIA, LUNCH SYMPOSIAGROUP 3 - SIMULTANEOUS STANDARD WORKSHOPSSESSION II: CONTROVERSIES IN CRITICAL CARE NEPHROLOGYSESSION III: EMERGING CONCEPTS IN AKI AND RRTFRIdAY, MARCH 9, 2018
MEET THE EXPERT SESSIONSSESSION IV: IMPROVING OUTCOMES IN AKISESSION V: FUTURE TRENDS IN CRRT AND CRITICAL CAREFACULTY dISCLOSURE

It is the policy of the University of California, San Diego School of Medicine to ensure balance,
independence, objectivity and scientific rigor. All persons involved in the selection, development
and presentation of content are required to disclose any real or apparent conflicts of interest. All
conflicts of interest will be resolved prior to an educational activity being delivered to learners
through one of the following mechanisms 1) altering the financial relationship with the commercial
interest, 2) altering the individual’s control over CME content about the products or services of thecommercial interest, and/or 3) validating the activity content through independent peer review. All
persons are also required to disclose any discussions of off label/unapproved uses of drugs ordevices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.

CULTURAL And LInGUISTIC COMpETEnCYThis activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills thatenables health care professionals or organizations to care effectively for patients from diverse cultures,groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about
AB1195 can be found on the UCSD CME website at http://cme.ucsd.edu.

CAnCELLATIOn pOLICY

If your registration must be cancelled, your fee, less $100 U.S. foradministrative costs, will be refunded upon your written request. No
refunds will be made after February 7, 2018. Allow 6-8 weeks for refund.

COnFEREnCE OFFICERES Seminars, 4425 Cass Street, Suite A
San Diego, CA 92109 USA

7

COnTACT InFO

RES/CRRT 2018
Phone: 858-272-1018
Fax:
858-272-7687
Email: crrt@res-inc.com
Website: www.crrtonline.com

pROGRAM

MOndAY, MARCH 5

4:00-7:00pm Conference Registration Open

7:00am-7:00pm

TUESdAY, MARCH 6

Conference Registration Open

pRE-COnFEREnCE AKI SYMpOSIUM - pw1 (CME Available)(see page 3 for elective symposium and workshop fees)

Changing paradigms in Acute Kidney Injury:
From Mechanisms to Management
Presented by UAB/UCSD O’Brien Center for AKI Research

CRRT Conference registration is NOT required for this elective symposium. See page 4 for details.

7:55 am

Opening Remarks - Ravindra Mehta, MD

8:00-8:20
8:20-8:40
8:40-9:00
9:00-9:20
9:20-9:40
9:40-10:00
10:00-10:15

HIF Signaling in AKI - Volker Haase
Cell death pathways in AKI - Andreas Linkermann
Iron and Innate Immunity in AKI: promising Therapeutic Targets - Swami Sundararaman
3d Imaging of Human Biopsies in AKI - Tarek M. Ashkar (El-Achkar)
Optogenetics in Understanding Mechanisms of AKI - Mark Okusa
discussion
Coffee Break

pLEnARY 1 Molecules, Mechanisms and Targets

Co-Chairs: Anupam Agarwal, MD and Robert Star, MD

pLEnARY 2 Of Mice and Men: Harmonizing Human and Animal AKI
Co-Chairs: Paul Sanders, MD and Prabhleen Singh, MD

10:15-10:35
Assessing Tubular Function during Injury and Repair from AKI - Volker Vallon
10:35-10:55
Lung-kidney Cross-talk: The Role of Mitochondrial dysfunction - Laura Crotty-Alexander
10:55-11:15
Sepsis Induced AKI: does Basic Science Match the Clinical Spectrum - John Kellum
11:15-11:35
Genomic determinants of AKI - David Leaf
11:35-11:55
Intestinal Microbiota in AKI - Hamid Rabb
11:55-12:15
discussion
12:15-1:15 pm
Lunch Hosted by Conference

pLEnARY 3 Bench to Bedside: Translating discoveries to Clinical Care
Co-Chairs: Mark Okusa, MD and Kathleen Liu, MD

2:55-3:15
3:15-3:30

Transcriptional profiling differentiates AKI Subtypes - Jonathan Barasch
Micro-RnA profile After Major Trauma and the Incidence of AKI and MOF - John Prowle
Urine proteomic Analysis: A Viable Approach to Identify Biomarkers in AKI - John Arthur
pre-implantation Kidney Biopsies as a predictor for delayed Graft Function - Roslyn Mannon
A Beta-HCG derivative Modulates the Immune Response and protects the Kidneys Peter Pickkers
discussion
Coffee Break

3:30-3:50
3:50-4:10
4:10-4:30
4:30-4:50
4:50-5:10
5:10-5:30
5:30

determining Renal Reserve in AKI - Claudio Ronco
do AKI Biomarker Trajectories provide a phenotype for AKI prediction? - Rajit Basu
AKI in Real Time: prediction, prognostication, and Alerts - Francis Perry Wilson
Assessing Renal Recovery after AKI: Can Biomarkers Help? - Zoltan Endre
Clinical Trial Endpoints in AKI: what Should we not Use? - Paul Palevsky
discussion
Adjourn

1:15-1:35
1:35-1:55
1:55-2:15
2:15-2:35
2:35-2:55

pLEnARY 4

5:30-7:00pm

Controversies in AKI

Co-Chairs: Mitch Rosner, MD and Stuart Goldstein, MD

Tuesday Evening Reception & poster Review - For All Conference Attendees

8

TUESdAY, MARCH 6

7:00am-7:00pm Conference Registration Open

pRE-COnFEREnCE wORKSHOp - pw2 (CME Available)

practice Based Learning in CRRT: The Science and the Art(see page 3 for elective symposium and workshop fees)

This workshop is designed to provide participants with the knowledge and understanding for decision making
for the effective utilization of CRRT to manage critically ill patients. The workshop will utilize case based
discussions and interactive sessions to illustrate the underlying concepts for application of CRRT. Delegateswill participate in group exercises to apply their learning for the management of complex cases. At the endof this workshop participants will have an improved understanding of how to utilize CRRT for optimizing
renal support. A quiz will be administered pre-and post- course for assessment.

Learning Objectives:•Describe the underlying concepts and review the process of decision making for prescribing anddelivering CRRT
•Learn machine set-up for different modalities, alarm conditions, troubleshooting, monitoring and charting•Utilize the tools provided to manage complex cases
Co-Chairs: Ashita Tolwani, MD and Jorge Cerda, MD
Faculty: David Askenazi, MD
Luis Juncos, MD, PhD
Linda Awdishu, PharmD, MAS Nithin Karakala, MD
Michael Connor, MD
Isagani Marquez, RN
Stuart Goldstein, MD
Theresa Mottes, RN

Noel Oabel, BSN, RN, CNN
David Selewski, MD
Teri Shell, RN

7:45-8:00am Opening Remarks - (Tolwani, Cerda)
8:00-8:30
pre-Test - (Tolwani, Cerda)
8:30-9:00
AKI and patient Selection for CRRT - (Cerda)
9:00-9:30
CRRT: The Technical Questions - Modality & dose - (Tolwani)
9:30-10:00
CRRT: The Technical Questions - Access, Membrane, Circuit - (Juncos)
10:00-10:15
Coffee Break
10:15-10:45 CRRT Outcome Studies: Survival and Renal Recovery - (Connor)
10:45-11:15
drug dosing - (Awdishu)
11:15-12:00 Interactive Case discussion - (Tolwani, Cerda)
12:00-1:00pm
Lunch Hosted by Conference for Workshop Participants
1:10-4:00
Interactive Sessions

These sessions will engage nurses and physicians in separate tracks. Physicians will be guided on user interfaces and thestrategies for prescribing dose for solute and fluid management, adjustments in therapy parameters, recognition and management of complications. Nurses will learn how to set up for different modalities and adjust and monitor for therapy delivery based on the prescription. pediatric teams will rotate only through the pediatric section.
physicians Track
Session 1: Circuit, Anticoagulation and Monitoring
Ashita Tolwani, Luis Juncos

nursing Track
Session 1: Machine priming, Circuit Set Up,
programing to Match Orders - Teri Shell

Session 2: dose / Fluid / documentation / Recognizing
and Managing Complications - Michael Connor

Session 3: prescription / Order Sets / decision Making /Coordination of Care - Jorge Cerda, Linda Awdishu

Session 4: Monitoring, Alarms and Connections with
Other Therapies - Keith Wille, Nithin Karkala

Session 2: Implementing Therapy delivery dose
Adjustments, Fluid Balance - Eileen Lischer

Session 3: Therapy Monitoring and Troubleshooting
Alarms, Therapy discontinuation - Noel Oabel

Session 4: Connectology with Hybrid Systems ECMO,ECCOR, Apheresis - Isagani Marquez

pediatric Track
Modality Selection, Circuit Modifications, Therapy dosing, Monitoring, Adjustments for Targeted Interventions
David Askenazi, Stuart Goldstein, David Selewski, Theresa Mottes

4:00-4:15
4:15-4:55
5:00-5:30
5:30

5:30-7:00pm

Coffee BreakInteractive Clinical Case (decision Making) - (Tolwani and CRRT Faculty)
post-test and wrap-up
Adjourn

Tuesday Evening Reception & poster Review - For All Conference Attendees

9wEdnESdAY MORnInG, MARCH 7

7:00am-4:30pm Conference Registration Open
7:00-8:15am MEET THE EXpERT - Breakfast Sessions (CME Available)(elective sessions, choose one, see pg. 4 for fees/details)

Session 1 (ME1) - My Approach to Oliguria
Claudio Ronco and Jean Louis Vincent

Session 2 (ME2) - How do I Manage the Obese patient in the ICU?
Lui Forni and Michael Joannidis

7:00-8:15am BREAKFAST SYMpOSIA - (CME Available, Seating is LIMITED)(continental breakfast provided by conference, selection made during registration)
Symposium A - Fluids and Vasopressor Management in the ICU
Michael Connor (Moderator)
Michael Pinsky and Jean Louis Vincent (Discussants)

This symposium will highlight the practical aspects of fluid and vasopressor management in critically illpatients. Which drugs are now available, what is the goal for management, which drugs are available
and how should they be selected, combined with other agents? How should they be monitored and adjusted?

Symposium B - Therapeutic Challenges in AKI and CKd: Managing Acid Base andElectrolyte problems
Andrew Lewington (Moderator)
Qi Qian and James Tumlin (Discussants)

SESSIOn I: pATIEnT CHARACTERISTICS (CME Available)

8:20-10:30am plenary 1 - MInI-SYMpOSIA
Organ Dysfunction in the Critically
Ill Patient: Emerging Concepts
Co-Chairs:
Kianoush Kashani and Miet Schetz
8:20-8:30

8:30-8:45

8:45-9:00

9:00-9:15

pathophysiological Basis of AKI in
Acute on Chronic Liver Failure
Rajiv Jalan
9:30-9:45
The Brain and the Kidney
Andrew Davenport
9:45-10:00 Towards precision Medicine in
Sepsis patients: Are we Close?
Peter Pickkers
10:00-10:30 SpECIAL LECTURE
Adaptive Responses to High Altitude
Inder Anand
9:15-9:30

Opening Remarks
Ravindra L Mehta
Cardio-pulmonary Interactions
Michael Pinsky
Lung - Kidney Cross Talk
Kathleen Liu
Shock in 2018: what do we Know?
Jean Louis Vincent

10:30-11:00 Coffee BreakFaculty Picture

10

wEdnESdAY MORnInG, MARCH 7

STAndARd wORKSHOpS - GROUP 1 (CME Available for All)
Open to all participants - applicable to physicians, nurses and allied personnel

Codes: C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = Nurses & Allied Personnel
Workshops presented in a series are marked with a “1” for a primary discussion and “2” for a more complex
or advanced discussion in the topic. Series workshops 1 and 2 can be taken subsequently (following eachother) or independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa).
workshop Tracks
A: Biomarkers; B: CRRT Technique; C: Critical Care Topics ; D: Organ Support ; E: Nursing; F: Plasma
Exchange, Hybrid Techniques and Pediatric Applications

11:00am-12:30pm GROUp 1 - SIMULTAnEOUS STAndARd wORKSHOpS (choose one)
A01
B02

C03
d04
E05

!
NEW Trackg
NursinSeries)(E

F06

Using Kidney Biomarkers for AKI: principles and practice (C,n,Ap)

Practical issues for use of kidney biomarkers for assessing risk and for early recognition andinterventions in AKI. (Murray, Basu, Bihorac)

Strategies for Optimizing the CRRT Circuit (Access, Anticoagulation andprogramatic Assessments) (C,n,Ap)

Case-based discussion on best practice for maintaining circuits for CRRT focusing on Access,Anticoagulation and program assessment. (Juncos, Ding, Askenazi)

Assessment of Fluid Responsiveness, Hemodynamic Monitoring and Targets (C, n)

Principles and strategies for volume assessment, hemodynamic and microcirculatory
monitoring in critically ill patients. (Pinsky, Pickkers)

Managing patients with AKI and Liver Failure 1: pathophysiology, differential
diagnosis, Use of RRT, Liver Support, Strategies for Bridge to Transplant (C,n,Ap)

Pathophysiology of AKI in setting of acute and chronic hepatic failure and management
strategies for differential diagnosis and therapy. (Nadim, Jalan, Davenport)

Establishing and Maintaining Core Competencies for nurses for CRRT (I,n,Ap)Core curriculum for nursing education, training and assessment of competencies for performing
RRT and extracorporeal support techniques. (Lischer, Mottes)

principles, Applications and practical Issues of plasma Exchange (C,n,Ap)

Rationale and technique of plasma exchange and its applications, case based discussions.
Technique adaptations for combining CRRT with other extracorporeal support therapies.
Circuit setup, logistics, monitoring and assuring safety. (Noiri, Sanchez, Marquez)

12:30-2:00pm LUnCH SYMpOSIA - (CME Available, Seating is LIMITED)(lunch provided by conference, selection made during registration)
w1 - Emerging Strategies for Monitoring Changes in Renal Structure and Function
Please note,
Moderators: Sandra Kane Gill and Eddie Siew
these are thepro-Enkephalin - Peter Pickkers
only lunch
options provided
Kinetic GFR - Marlies Ostermann
on Wednesday
Contrast Enhanced Ultrasound - TBD
w2 - Fluid Management of the Critically Ill patient: when to Use Crystalloids,
Colloids and Blood products
Moderators: Miet Schetz and Hiroyuki Hirasawa
Early Resuscitation - Jean Louis Vincent
Optimization and Maintenance - Lui Forni
descalation and Restoration of Homeostasis - Kianoush Kashani
w3 - Multiorgan Support Therapies (MOST): Are we Ready?
Moderators: Claudio Ronco and Eisei Noiri
Combined Renal and Respiratory Support - Zaccaria Ricci
Liver Support (MARS) - Rajiv Jalan
Apheresis and Sorbent Therapies - Patrick Honoré
w4 - Management of AKI in Sepsis: Challenges and Opportunities?
Moderator: Azra Bihorac and Patrick Murraypathophysiology of AKI in Sepsis - John Kellum
Role of hemodynamics in Sepsis - Michael Pinsky
Therapeutic Targets and Interventions - Michael Joannidis
I1 - Additional Session Offered - Non-CME - See page 4 for details

11wEdnESdAY AFTERnOOn, MARCH 7

STAndARd wORKSHOpS - GROUP 2 (CME Available for All)GROUp 2 - SIMULTAnEOUS STAndARd wORKSHOpS (choose one)

2:00-3:30pm
A07

Using Kidney Biomarkers for Guiding drug Therapy (C,n,Ap)

Review limitations of existing approaches to assessment and interpretation of kidney function.
Discuss how novel renal biomarkers can be leveraged to guide medication therapy in criticallyill patients with a focus on optimization of drug dosing to limit drug induced kidney disease.
(Endre, Gill, Barreto)

B08

CRRT for the Experienced User 1 (I,n,Ap)Interactive case based discussions on dose adjustments, monitoring for adequacy, modality selection
and transitions in CRRT. (Claure, Ronco, Selewski)

C9

Starting, Transitioning and Stopping RRT for AKI: Science and Art (A)Principles of determining when to start and stop RRT. Case based discussion ofvarious approaches. (Macedo, Mehta)

d10Managing patients with Sepsis: pathophysiology, diagnosis, Assessment,
Resuscitation, drug Management, Techniques for disease Modification, Organ
Support and Renal protection (C,n,Ap)

E11

Quality Metrics in AKI and CRRT: Establishing Benchmarks (I,n,Ap)

Case based discussions on pathophysiology of sepsis, rationale and strategies for fluid andvasopressor use for supportive therapy with the sepsis bundle. Technical considerations andpractical application of extracorporeal support techniques for sepsis. Results of human studies
for use of high permeability membranes, HVHF, VHVHF and hybrid techniques for sepsis.
(Vincent, Pickkers, Fleming)!
NEW Track Determining quality metrics for AKI care delivery and RRT. What criteria, how should they begNursinSeries)
monitored and utilized to improve patience care and outcomes. (Tolwani, Selby, Ricci)(E

F12

Sorbent Based and Hybrid Therapies for Extracorporeal Support (I,n,Ap)

Hemopurification systems for sepsis, immunoadsoprtion and PMMA.
(Hirasawa, Honoré, Ding)

3:30-4:00pm

Coffee BreakSESSIOn I: pATIEnT CHARACTERISTICS - continued (CME Available)

4:00-6:00pm plenary 2 - MInI-SYMpOSIA
Acute Kidney Injury (AKI):
Pathophysiology
Co-Chairs:
Jay Koyner
4:00-4:15

4:15-4:30
4:30-4:45
4:45-5:00

5:00-5:15

5:15-5:30

does Hypoalbuminema
Cause AKI?
Michael Joannidis

5:30-6:00

pathogenesis of AKI in
Heart Failure: Insights from
Biomarker Studies
Patrick Murray

6:00pmClinical Trajectories of
AKI in Sepsis
Azra Bihorac

personalized Bp Management to
Optimize Organ perfusion
Michael Pinsky

Are SGLT-2 Inhibitors Risk
Factors for AKI?
Peter McCullough

SpECIAL LECTURE
precision Medicine and theKidneyRobert Star
Adjourn

6:00-8:00pm EXHIBIT RECEpTIOn And
pOSTER SESSIOn

TAVR and AKI:
Cause or Consequence?
Kianoush Kashani

12THURSDAY MORNING, MARCH 8

7:00am-4:30pm Conference Registration Open
7:00-8:15am MEET THE EXPERT - Breakfast Sessions (CME Available)(elective sessions, choose one, see pg. 4 for fees/details)
Session 3 (ME3) - What do I do to Prevent Contrast Induced Renal Injury
Peter McCullough and Paul Palevsky
Session 4 (ME4) - How do I Manage Difficult Communications with Patients
Noel Gibney and Steve Alexander

7:00-8:15am BREAKFAST SYMPOSIA - (CME Available, Seating is LIMITED)(continental breakfast provided by conference, selection made during registration)
Symposium C - Innovations in Caring for Patients with Hypo and Hypernatremia
Andrew Davenport and Jordan Symons (Moderators)
Qi Qian and James Tumlin (Discussants)
This symposium will cover the pathophysiology of hypo and hypernatremia anddiscuss the practical issues for management of these disorders with novel agents
Symposium D - Imaging Techniques in Critically Ill Patients with Kidney Disease
John Prowle and Erin Barretto (Moderators)
Nick Selby and Miet Schetz (Discussant)STANDARD WORKSHOPS - GROUP 3 (CME Available for All)

8:15-9:45am GROUP 3 - SIMULTANEOUS STANDARD WORKSHOPS (choose one)
A13
B14
C15
D16
E17

!
NEW Trackg
NursinSeries)(E

F18

9:45-10:15am

Preventing AKI: From Surveillance to Intervention (C,N,AP)

This workshop will describe the current status of methods to identify patients at high risk for
AKI and techniques for electronic surveillance. Strategies and tools for preventing AKI in
different settings will be discussed. (Lewington, Kashani, Siew)

CRRT for the Experienced User 2: Solutions, Fluid Removal,
Fluid Balance, Monitoring (A)Interactive case based discussion on strategies for fluid management in CRRT to achieve
patient driven outcomes for fluid, electrolyte and acid base balance. (Prowle, Mehta)

Drug Induced Kidney Injury: Mechanisms, Susceptibility, Diagnosis,
Management Strategies (A,N)

Causes and consequences of drug induced nephrotoxicity, factors contributing to toxicity,
strategies for preventing and managing toxicity. Drug dosing during dialysis techniques.
(Awdishu, Gill, Goldstein)

Managing Heart Failure and Cardio-Renal Syndrome: Pathophysiology,
Diagnosis, Drug Management, Ultrafiltration, Renal Support and RRT for
Patients with Ventricular Assist Devices and Artificial Hearts (A,N)

Technical considerations, practical application and results of different methods to treat heart
failure and cardio-renal syndrome including ultrafiltration techniques. (Maisel, Juncos, Anand)

Patient Centered Care: Ensuring Quality of Life Outcomes for Patients on
RRT in the ICU (I,N,AP)

Role of mobility and functional status assessments, patient and care giver communications,management of post intensive care syndrome. (Gibney, Schetz)

Pediatric AKI and CRRT: How do I Care for My Patient and My Program? (I,N,AP)

Review and discussion of best practices to develop your pediatric AKI and CRRT program,
identify and treat your young patients with AKI, and to assure delivery of high-quality care in
the pediatric setting. (Ricci, Mottes, Symons)

Coffee BreakSESSION II: CONTROVERSIES IN CRITICAL CARE NEPHROLOGY (CME Available)

10:15am-12:30pm Plenary 3 - MINI-SYMPOSIA
Challenges in ICU Management
Chair:
Zaccaria Ricci
10:15-10:30 Are Balanced Solutions the Solution?
Edward Siew
10:30-10:45 Preventing AKI in the ICU: Current
Guidelines - Michael Joannidis
10:45-11:00 Multiparametric MRI in theAssessment of AKI - Nick Selby
11:00-11:15 Albumin in Cirrhosis: More thanjust a Fluid Expander - Rajiv Jalan

13

11:15-11:30 Functional Hemodynamic
Management: Does it Work?
Michael Pinsky
11:30-11:45 The Hospital of Tomorrow
Jean Louis Vincent
11:45-12:15 SPECIAL LECTURE
Translating to Management Award
AKI: From Clinical to
Molecular Diagnosis
Claudio Ronco
12:15-12:30 Top Abstract Awards

THURSdAY AFTERnOOn, MARCH 8

12:30-2:00pm LUnCH SYMpOSIA - (CME Available for T1, T2, T3 & T4, Seating is LIMITED)(lunch provided by conference, selection made during registration)

T1 - personalized Care for AKI: do Biomarkers Help?
Moderators: Kianoush Kashani and John Kellum
Discussants: Alex Zarbock, Claudio Ronco, Jay Koyner
T2 - Hydration and Kidney HealthModerator: Marlies Ostermann
pathophysiology of water Handling by the Kidney - Qi Qian
dehydration and AKI: Association or Cause? - Emmanuel Burdmann
Hydration Status and Kidney disease: does it Affect progression? - Magdelena Madero
T3 - AKI in the patient with Cancer
Moderators: Steve Alexander and David Wardpathophysiology and Mechanisms - Mitch Rosner
Imaging techniques and Risk for AKI - Peter McCullough
Renal Function Monitoring - Stuart Goldstein
T4 - Can Big data drive Better Care for AKI?
Moderators: Andrew Lewington and Li Yang
what is Big data and where Can You Get It - Scott Sutherland
Leveraging Big data in AKI and CRRT - Sean Bagshaw
Using Big data to Target Specific Treatments to Individual patients - Francis Perry Wilson

I2 - Additional Session Offered - Non-CME - See page 4 for details

SESSIOn III: EMERGInG COnCEpTS In AKI And RRT (CME Available)

2:00-3:45pm plenary 4 - MInI-SYMpOSIA
Novel Strategies in AKI Management
Co-Chairs:
Eisei Noiri and Andrew Lewington
2:00-2:15
Heart Failure and Kidney disease:
The KdIGO Controversies ConferencePeter McCullough
2:15-2:30
After the Fall: post-AKI Outcomesand potential Intervention points
Edward Siew
2:30-2:45
Establishing Sub phenotypes of AKI:The SIRE Approach
Ravindra Mehta
2:45-3:00
predicting AKI in Acute Medical
patients; Is it possible?
Lui Forni
3:00-3:15
we do not need ‘AKI’ - Renal
Failure is part of MOF
Jean Louis Vincent
3:15-3:30
KdIGO UOp vs. SCr AKI
Criteria, does it Matter?
Scott Sutherland
3:30-3:45
Functional and damage
Biomarkers in Subclinical CKd
Zoltan Endre
3:45-4:15
Coffee Break

4:15-6:00pm plenary 5 - MInI-SYMpOSIA
Challenges and Controversies in
Renal Support and CRRT
Co-Chairs:
Ashita Tolwani and Stuart Goldstein
4:15-4:30
Blood purification for Sepsis which Molecules Should we Remove?
Hiroyuki Hirasawa
4:30-4:45
does Albumin Replacement
Improve Fluid Removal and Reduce
Intradialytic Complications?
Ravindra Mehta
4:45-5:00
nutritional Changes post AKI
Etienne Macedo
5:00-5:30
SpECIAL LECTURE
Management of AKI post Cardiac
and Vascular Surgery:
Highlights from AdQI 19
Mitra Nadim
5:30-6:00
Viewpoints: nephrologists Should be
Consulted for all Cases of AKI in
the ICU
No it is Not Required - John Kellum
We are Not Sure - Miet Schetz
Yes Absolutely - Claudio Ronco
Moderator - Paul Palevsky
6:00
Adjourn - Free Evening

14

FRIdAY MORnInG, MARCH 9

7:00am-1:00pm Conference Registration Open
6:45-8:00am MEET THE EXpERT - Breakfast Sessions (CME Available)(elective sessions, choose one, see pg. 4 for fees/details)
Session 5 (ME5) - How do I Implement a KdIGO Bundle in My ICU
John Kellum and Alex Zarbock
Session 6 (ME6) - Forget the Evidence: when do I Use diuretics?
Lui Forni and Sean Bagshaw
6:45-8:00am I3 - Additional Breakfast Session Offered - Non-CME - See page 4 for details
7:30-8:00am
Coffee Served

SESSIOn IV: IMpROVInG OUTCOMES In AKI (CME Available)

8:00-10:30am plenary 6 - MInI SYMpOSIA
Global Burden of AKI
Chair:
Xiaoquiang Ding and Andrew Lewington
8:00-8:15 AKI and the Global Burden of
diseaseJorge Cerda
8:15-8:30 CKd of Unknown Origin (CKdu):
AKI in disguise?
Magdelena Madero
8:30-8:45 nationwide Epidemiology andprognosis of dialysis-requiring
Acute kidney Injury(nEp-AKI-d) Study
Vincent Wu
8:45-9:00 preventing Contrast Induced AKI:
The pRESERVE Trial
Paul Palevsky
9:00-9:15 Obstetric AKI: Still a problem
Kate Bramham

9:15-9:30

Education and Training to Raise
Awareness of AKI in the Community
TBD
9:30-9:45 The ISn 0by25 AKI pilot Study:
what Have we Learnt?
Etienne Macedo
9:45-10:00 Tackling AKI: The Quality
Improvement Study
Nick Selby
10:00-10:15 AKI in China: Results of anationwide Survey
Li Yang
10:15-10:30 Clinical-pathological Correlations
in AKI
Sanjay Agarwal
10:30-11:00 Coffee Break

11:00am-1:00pm plenary 7
MInI SYMpOSIA
Emerging Strategies in AKI and
Extracorporeal Support
Co-Chairs:
Vincent Wu and Jorge Cerda

4. STAART AKI Trial Update
Sean Bagshaw
5. Ketoacid Supplementation andRenal Recovery post AKI
Vivek Kumar
6. Endotoxin Removal for Sepsis:
The EUpHRATES Trial
Patrick Honoré
12:30-12:55 Critical Care nephrology:
Literature Review
Noel Gibney
12:55-1:00 Closing Remarks
Ravindra L. Mehta

SESSIOn V: FUTURE TREndS In CRRT And CRITICAL CARE (CME Available)

11:00-12:30 Update from Ongoing andLate Breaking Trials
12 minutes each

1. The ASSESS AKI Study:
what Have we Learned?
Edward Siew
2. Alkaline phosphatase for
Septic AKI
Peter Pickkers
3. Angiotensin II in Shock:
The ATHOS2 Trial
James Tumlin

March 6-9, 2018

AKI&CRRT 2018

1:00pmFeb. 26-Mar 1, 2019

AKI&CRRT 201915

Chairman

Conference Adjourns

February 25-28, 2020

AKI&CRRT 2020

AKI & CRRT 2018
March 6-9, 2018Mark These Dates in Your Calendar Also!!!

AKI & CRRT 2019Feb. 26 - MaR. 1, 2019

AKI & CRRT 2020Feb. 25-28, 2020

crrtonline.com

March 6-9, 2018
San Diego, California

Updates in ICU Medicine:
Controversies, Challenges and Solutions

AKI & CRRT 2018

TWENTY THIRD INTERNATIONAL CONFERENCE ON
ADVANCES IN CRITICAL CARE

AKI & CRRT 2018
c/o RES Seminars
4425 Cass Street, Suite A
San Diego, CA 92109 USA